MoneyWorks4Me

Marksans Pharma’s arm receives marketing authorization for Gabapentin

15 May 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received marketing authorization for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

318.15 -5.85 (-1.81%)
25-Aug-2026 14:47 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1912.10
Dr. Reddys Labs. 1186.90
Cipla 1416.90
Lupin 2172.85
Zydus Lifesciences 1113.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: